🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Filgrastim (G-CSF) is widely used for treatment of patients who have a defi...
Status
Completed
Location
USF/Byrd Alzheimer's Center
Start Date
2009-06
Trial ID
NCT01617577
Treatments Being Tested
This is a dose finding study of a novel radiopharmaceutical agent, 153Sm-DO...
Status
Withdrawn
Location
Montefiore Medical Center-Children's Hospital
Start Date
2022-08
Trial ID
NCT03612466
Treatments Being Tested
This is a study comparing two study drugs, Filgrastim Hospira and Neupogen®...
Status
Completed
Location
SeaView Research, Inc
Start Date
2015-12
Trial ID
NCT02766647
Treatments Being Tested
The research study is being conducted to study whether performing injection...
Status
Not Yet Recruiting
Location
Abramson Cancer Center at the University of Pennsylvania
Start Date
2026-09-01
Trial ID
NCT07059611
This is a Phase 2 study during which patients with advanced multiple myelom...
Status
Completed
Location
Genesis Cancer Center
Start Date
2013-11
Trial ID
NCT01989325
The purpose of this study is to finalise the development of a process for t...
Status
Unknown
Location
CIC Paris Est, Hôpital Pitié Salpêtrière
Start Date
2022-04-26
Trial ID
NCT05118113
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, etoposide ...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2004-12
Trial ID
NCT00238173
The purpose of this study is to determine whether accelerated BEP chemother...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Centre
Start Date
2014-02
Trial ID
NCT02582697
To evaluate the safety and feasibility of collecting hematopoietic stem cel...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-05-20
Trial ID
NCT06414889
Treatments Being Tested
The goal of this clinical research study is to learn the most tolerable dos...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-10-29
Trial ID
NCT00943943
Treatments Being Tested